产品
编 号：F301073
分子式：C68H109N17O22S2
分子量：1580.82
分子式：C68H109N17O22S2
分子量：1580.82
产品类型
规格
价格
是否有货
结构图
CAS No: 272105-42-7
产品详情
生物活性：
Disitertide (P144) is a peptidic transforming growth factor-beta 1 (TGF-β1) inhibitor specifically designed to block the interaction with its receptor. Disitertide (P144) is also a PI3K inhibitor and an apoptosis inducer.
体内研究：
Disitertide (Topical application, 300 μg/mL) may promote scar maturation and improvement of hypertrophic scar morphology features in an “in vivo” model in nude mice after two weeks of treatment.Animal Model:Human hypertrophic scars were implanted in 60 nude mice.
Dosage:300 μg/mL was added the Lipogel.
Administration:Topical application daily administered.
Result:Successful shedding was achieved in 83,3% of the xenografts.
体外研究：
Disitertide (P144, 100 μg/mL) suppresses the protein expression levels of PI3K and p-Akt, and induce the protein expression of Bax in MC3T3-E1 cells. Disitertide (TGF-β1 inhibitor) abrogates the MACC1- AS1 expression in GC cells, suggesting that targeting TGFβ signaling pathway may be a potential strategy to inhibit MSC-induced stemness and chemoresistance.Disitertide (10 μg/mL to 200 μg/mL) affects proliferation, induces apoptosis as well as anoikis in A172 and U-87 MG GBM cell lines.
Disitertide (P144) is a peptidic transforming growth factor-beta 1 (TGF-β1) inhibitor specifically designed to block the interaction with its receptor. Disitertide (P144) is also a PI3K inhibitor and an apoptosis inducer.
体内研究：
Disitertide (Topical application, 300 μg/mL) may promote scar maturation and improvement of hypertrophic scar morphology features in an “in vivo” model in nude mice after two weeks of treatment.Animal Model:Human hypertrophic scars were implanted in 60 nude mice.
Dosage:300 μg/mL was added the Lipogel.
Administration:Topical application daily administered.
Result:Successful shedding was achieved in 83,3% of the xenografts.
体外研究：
Disitertide (P144, 100 μg/mL) suppresses the protein expression levels of PI3K and p-Akt, and induce the protein expression of Bax in MC3T3-E1 cells. Disitertide (TGF-β1 inhibitor) abrogates the MACC1- AS1 expression in GC cells, suggesting that targeting TGFβ signaling pathway may be a potential strategy to inhibit MSC-induced stemness and chemoresistance.Disitertide (10 μg/mL to 200 μg/mL) affects proliferation, induces apoptosis as well as anoikis in A172 and U-87 MG GBM cell lines.
产品资料
Copyright©2015-2024 沪ICP备2022026524号-1
沪公网安备